bioavailability enhancement technologies lp

Bioavailability enhancement technologies for poorly soluble molecules

Explore the capabilities of Patheon’s Quadrant 2® AI/ML-powered predictive computational model platform

Solubility issues are an increasing threat to advancing small molecules successfully through the drug development pipeline. Learn how Quadrant 2 is helping developers avoid potentially devastating setbacks by using information about your molecule and your business objectives to identify the solubility enhancement technology and excipient combinations most likely to succeed.

Explore the interactive infographic to discover more about using Quadrant 2 to:

Analyze your API’s chemical structure and known physiochemical properties

Identify possible solubility enhancement technologies like spray drying, HME, lipid formulations, and solid-state chemistry

Pinpoint the solubility enhancement technologies most likely to succeed for your molecule

Align solubility and bioavailability solutions with your business and clinical goals

First Name

Last Name

Phone Number

Company

Job Title

Single Line Text

Function

Industry

Single Line Text

Line Company Text

Checkboxes

You agree Citeline and Thermo Fisher Scientific may contact you directly about industry news, products, services and events that may be of interest to you subject to the privacy policies of Citeline and Thermo Fisher Scientific.